Literature DB >> 25958947

Crisis as a serendipity for change in Cyprus' healthcare services.

Panagiotis Petrou1.   

Abstract

As Cyprus signed a financial agreement with a team of international lenders, several reform measures were outlined as pre-requisites for disbursement of financial instalments. The health sector was massively reformed in order to enhance efficiency and reduce waste. The magnitude of reforms included introduction of guidelines and clinical algorithms, co-payments, and revision of criteria for public beneficiary status. In order to safeguard equity in access, solidarity in coverage and sustainability of its healthcare sector, reforms must continue unabated and, more importantly, the introduction of a universal health system should be the ultimate goal.

Keywords:  Cyprus; Efficiency; Financial Crisis; Reforms; Troika

Mesh:

Year:  2015        PMID: 25958947     DOI: 10.3111/13696998.2015.1049179

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  4 in total

1.  Cost-Sharing Rates Increase During Deep Recession: Preliminary Data From Greece.

Authors:  Athanasios Gouvalas; Michael Igoumenidis; Mamas Theodorou; Kostas Athanasakis
Journal:  Int J Health Policy Manag       Date:  2016-05-28

2.  The burden of disease in Greece, health loss, risk factors, and health financing, 2000-16: an analysis of the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Public Health       Date:  2018-07-25

3.  The contribution of Cyprus to non-communicable diseases and biomedical research from 2002 to 2013: implications for evidence-based health policy.

Authors:  Elena Pallari; Grant Lewison; Chryso Th Pallari; George Samoutis; Mursheda Begum; Richard Sullivan
Journal:  Health Res Policy Syst       Date:  2018-08-17

4.  Will the Economic Recession Inhibit the Out-of-Pocket Payment Willingness for Health Care?

Authors:  Yuhang Zheng; Zhehao Huang; Tianpei Jiang
Journal:  Int J Environ Res Public Health       Date:  2020-01-22       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.